Groncki-white Dental Associates, Pc | |
350 N Main St Ste 200 Chalfont PA 18914-2707 | |
(215) 822-3838 | |
Not Available |
Full Name | Groncki-white Dental Associates, Pc |
---|---|
Speciality | Dentist |
Location | 350 N Main St Ste 200, Chalfont, Pennsylvania |
Authorized Official Name and Position | Sarah White (CO-OWNER) |
Authorized Official Contact | 2152065152 |
Accepts Medicare Insurance | This clinic does not participate in Medicare Program. |
Mailing Address | Practice Location Address |
---|---|
Groncki-white Dental Associates, Pc 110 David Ln Lansdale PA 19446-1562 Ph: (215) 479-8018 | Groncki-white Dental Associates, Pc 350 N Main St Ste 200 Chalfont PA 18914-2707 Ph: (215) 822-3838 |
NPI Number | 1003546557 |
---|---|
Provider Enumeration Date | 06/15/2022 |
Last Update Date | 06/15/2022 |
Identifier | Type | State | Issuer |
---|---|---|---|
1003546557 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
122300000X | Dentist | (* (Not Available)) | Primary |
News Archive
Rutgers scientists think they have found a way to prevent and possibly reverse the most debilitating symptoms of a rare, progressive childhood degenerative disease that leaves children with slurred speech, unable to walk, and in a wheelchair before they reach adolescence.
A new technique based on the same technology used to detect chemical warfare agents and explosives is being employed by scientists at The University of Manchester to treat hospital patients with lung disease.
Pluristem Therapeutics Inc. today announced that it has entered into definitive agreements with selected investors to sell restricted common stock and warrants for aggregate gross proceeds of approximately $2.7 million. The offering includes 2,420,293 shares of common stock, warrants to purchase 726,088 shares of common stock at an exercise price of $1.25 per share and warrants to purchase 726,088 shares of common stock at an exercise price of $1.40 per share.
In a medical breakthrough scientists have found that gene therapy could be used to cure leukemia. Researchers at the University of Pennsylvania engineered patients' own pathogen-fighting T-cells to target a molecule found on the surface of leukemia cells. These genetically modified T-cells were grown outside of the body and infused back into patients suffering from late-stage chronic lymphocytic leukemia (CLL), which affects the blood and bone marrow and is the most common form of leukemia.
› Verified 2 days ago
Spillane Orthodontics Dental Clinic Medicare: Not Enrolled in Medicare Practice Location: 530 W Butler Ave, Chalfont, PA 18914 Phone: 215-822-2005 Fax: 215-997-8510 | |
Chalfont Dentistry Pc Dental Clinic Medicare: Not Enrolled in Medicare Practice Location: 3425 Limekiln Pike Ste 5, Chalfont, PA 18914 Phone: 215-997-4434 | |
A Plus Family Dental Care P.c. Dental Clinic Medicare: Not Enrolled in Medicare Practice Location: 1500 Horizon Dr, Suite#104, Chalfont, PA 18914 Phone: 215-997-9980 Fax: 215-997-9495 | |
Highpoint Pediatric Dental Associates Dental Clinic Medicare: Not Enrolled in Medicare Practice Location: 1600 Horizon Dr ., Suite 101, Chalfont, PA 18914 Phone: 215-822-4042 | |
Anthonly H Mapes Omd Pc Dental Clinic Medicare: Not Enrolled in Medicare Practice Location: 24 Main Street, Chalfont, PA 19814 Phone: 215-822-3569 Fax: 215-822-0387 | |
Chalfont Dental Care Pc Dental Clinic Medicare: Not Enrolled in Medicare Practice Location: 8 Meadowbrook Ln, Chalfont, PA 18914 Phone: 215-822-6234 Fax: 215-822-6373 |